NIFTY  8,879.60  -0.19%
  SENSEX  28,743.30  -0.24%
 CURRENCY  Rs  66.71/$ 70.60/€, 82.92/£
  GOLD  29,582.00  -0.43%
  SILVER  43,291.00  -0.31%
  DAX  11,822.70  0.16%
  FTSE  7,253.00  0.13%
  CAC  4,845.18  -0.00%
  HANG SENG  23,740.70  -0.77%
  NIKKEI  19,119.00  0.06%
  Shanghai Composite  3,241.73  0.22%
  DOW JONES  20,837.40  0.07%
  NASDAQ  5,861.90  0.28%
  S&P 500  2,369.75  0.10%
DEA SECRETARY - GDP Completely Negates Note Ban Apprehensions DEA SECRETARY - Manufacturing Sector Growth Is Very Satisfying

Looking To Enter High Potential Mkts: Lupin

Video:

Play this video

January 13: Lupin has been in the news off late, after it received the U.S. FDA approval for hypertension drug Twynsta, adding yet another product to its expanding portfolio. Mini Menon caught up with Nilesh Gupta, MD, Lupin to find out what the road ahead is looking like for the company and how it plans to expand its global reach.